Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ultromics Granted FDA Breakthrough Device Designation for AI-Enhanced Cardiac Amyloidosis Detection
Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
Ultromics, a leader in AI enabled cardiovascular imaging solutions, announced today that it has raised […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more